1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Medical Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Sepsis Biomarkers
  • 1.2.3 Antibiotic Resistance Biomarkers
  • 1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
  • 1.2.5 Stroke Testing Biomarkers
  • 1.2.6 Antibiotic Stewardship Biomarkers
  • 1.2.7 Other
• 1.3 Market by Application
  • 1.3.1 Global Medical Biomarkers Market Share by Application: 2020 VS 2026
  • 1.3.2 Diagnostics
  • 1.3.3 Drug Discovery
  • 1.3.4 Personalized Medicine
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Medical Biomarkers Market Perspective (2015-2026)
• 2.2 Global Medical Biomarkers Growth Trends by Regions
  • 2.2.1 Medical Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Medical Biomarkers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Medical Biomarkers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Medical Biomarkers Players by Market Size
  • 3.1.1 Global Top Medical Biomarkers Players by Revenue (2015-2020)
  • 3.1.2 Global Medical Biomarkers Revenue Market Share by Players (2015-2020)
• 3.2 Global Medical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Medical Biomarkers Revenue
• 3.4 Global Medical Biomarkers Market Concentration Ratio
  • 3.4.1 Global Medical Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Medical Biomarkers Revenue in 2019
• 3.5 Key Players Medical Biomarkers Area Served
• 3.6 Key Players Medical Biomarkers Product Solution and Service
• 3.7 Date of Enter into Medical Biomarkers Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Medical Biomarkers Breakdown Data by Type (2015-2026)

• 4.1 Global Medical Biomarkers Historic Market Size by Type (2015-2020)
• 4.2 Global Medical Biomarkers Forecasted Market Size by Type (2021-2026)

5 Medical Biomarkers Breakdown Data by Application (2015-2026)

• 5.1 Global Medical Biomarkers Historic Market Size by Application (2015-2020)
• 5.2 Global Medical Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Medical Biomarkers Market Size (2015-2026)
• 6.2 North America Medical Biomarkers Market Size by Type (2015-2020)
• 6.3 North America Medical Biomarkers Market Size by Application (2015-2020)
• 6.4 North America Medical Biomarkers Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Medical Biomarkers Market Size (2015-2026)
• 7.2 Europe Medical Biomarkers Market Size by Type (2015-2020)
• 7.3 Europe Medical Biomarkers Market Size by Application (2015-2020)
• 7.4 Europe Medical Biomarkers Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Medical Biomarkers Market Size (2015-2026)
• 8.2 China Medical Biomarkers Market Size by Type (2015-2020)
• 8.3 China Medical Biomarkers Market Size by Application (2015-2020)
• 8.4 China Medical Biomarkers Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Medical Biomarkers Market Size (2015-2026)
• 9.2 Japan Medical Biomarkers Market Size by Type (2015-2020)
• 9.3 Japan Medical Biomarkers Market Size by Application (2015-2020)
• 9.4 Japan Medical Biomarkers Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Medical Biomarkers Market Size (2015-2026)
• 10.2 Southeast Asia Medical Biomarkers Market Size by Type (2015-2020)
• 10.3 Southeast Asia Medical Biomarkers Market Size by Application (2015-2020)
• 10.4 Southeast Asia Medical Biomarkers Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Medical Biomarkers Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Medical Biomarkers Business (2015-2020))
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Merck Business Overview
  • 11.2.3 Merck Medical Biomarkers Introduction
  • 11.2.4 Merck Revenue in Medical Biomarkers Business (2015-2020)
  • 11.2.5 Merck Recent Development
• 11.3 Bio-Rad Laboratories
  • 11.3.1 Bio-Rad Laboratories Company Details
  • 11.3.2 Bio-Rad Laboratories Business Overview
  • 11.3.3 Bio-Rad Laboratories Medical Biomarkers Introduction
  • 11.3.4 Bio-Rad Laboratories Revenue in Medical Biomarkers Business (2015-2020)
  • 11.3.5 Bio-Rad Laboratories Recent Development
• 11.4 QIAGEN
  • 11.4.1 QIAGEN Company Details
  • 11.4.2 QIAGEN Business Overview
  • 11.4.3 QIAGEN Medical Biomarkers Introduction
  • 11.4.4 QIAGEN Revenue in Medical Biomarkers Business (2015-2020)
  • 11.4.5 QIAGEN Recent Development
• 11.5 Roche
  • 11.5.1 Roche Company Details
  • 11.5.2 Roche Business Overview
  • 11.5.3 Roche Medical Biomarkers Introduction
  • 11.5.4 Roche Revenue in Medical Biomarkers Business (2015-2020)
  • 11.5.5 Roche Recent Development
• 11.6 Danaher Corporation
  • 11.6.1 Danaher Corporation Company Details
  • 11.6.2 Danaher Corporation Business Overview
  • 11.6.3 Danaher Corporation Medical Biomarkers Introduction
  • 11.6.4 Danaher Corporation Revenue in Medical Biomarkers Business (2015-2020)
  • 11.6.5 Danaher Corporation Recent Development
• 11.7 Siemens Healthcare
  • 11.7.1 Siemens Healthcare Company Details
  • 11.7.2 Siemens Healthcare Business Overview
  • 11.7.3 Siemens Healthcare Medical Biomarkers Introduction
  • 11.7.4 Siemens Healthcare Revenue in Medical Biomarkers Business (2015-2020)
  • 11.7.5 Siemens Healthcare Recent Development
• 11.8 Abbott
  • 11.8.1 Abbott Company Details
  • 11.8.2 Abbott Business Overview
  • 11.8.3 Abbott Medical Biomarkers Introduction
  • 11.8.4 Abbott Revenue in Medical Biomarkers Business (2015-2020)
  • 11.8.5 Abbott Recent Development
• 11.9 Agilent Technologies
  • 11.9.1 Agilent Technologies Company Details
  • 11.9.2 Agilent Technologies Business Overview
  • 11.9.3 Agilent Technologies Medical Biomarkers Introduction
  • 11.9.4 Agilent Technologies Revenue in Medical Biomarkers Business (2015-2020)
  • 11.9.5 Agilent Technologies Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Medical Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other

Market segment by Application, split into
Diagnostics
Drug Discovery
Personalized Medicine
Other

Based on regional and country-level analysis, the Medical Biomarkers market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Medical Biomarkers market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott